|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Product sales | |||||
| Other revenues | |||||
| REVENUES | |||||
| Cost of goods and services | |||||
| Research and development expenses | |||||
| Marketing and distribution expenses | |||||
| General and administrative expenses | |||||
| Other income and expenses, net | |||||
| OPERATING PROFIT/(LOSS) | |||||
| Finance income | |||||
| Finance expenses | |||||
| Foreign exchange gain/(loss), net | |||||
| Result from investments in associates | |||||
| PROFIT/(LOSS) BEFORE INCOME TAX | |||||
| Income tax benefit/(expense) | |||||
| PROFIT/(LOSS) FOR THE PERIOD | |||||
| Earnings/(losses) per share for profit/(loss) for the period attributable to the equity holders of the Company (expressed in € per share) | |||||
| Basic earnings (losses) per share for profit (loss) for the period attributable to the equity holders of the Company (in euro per share) | |||||
| Diluted earnings (losses) per share for profit (loss) for the period attributable to the equity holders of the Company (in euro per share) |
Loading...
